AAAAAA

   
Results: 1-25 |
Results: 25
Polylysine as a vehicle for extracellular matrix-targeted local drug delivery, providing high accumulation and long-term retention within the vascular wall
Authors: Sakharov, DV Jie, AFH Bekkers, MEA Emeis, JJ Rijken, DC
Citation: Dv. Sakharov et al., Polylysine as a vehicle for extracellular matrix-targeted local drug delivery, providing high accumulation and long-term retention within the vascular wall, ART THROM V, 21(6), 2001, pp. 943-948
Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol
Authors: Burggraaf, J Lalezari, S Emeis, JJ Vischer, UM de Meyer, PHEM Pijl, H Cohen, AF
Citation: J. Burggraaf et al., Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol, THYROID, 11(2), 2001, pp. 153-160
Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria
Authors: Jager, A van Hinsbergh, VWM Kostense, PJ Emeis, JJ Nijpels, G Dekker, JM Heine, RJ Bouter, LM Stehouwer, CDS
Citation: A. Jager et al., Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria, NEPH DIAL T, 16(3), 2001, pp. 529-536
Progression of diabetic nephropathy: Role of plasma homocysteine and plasminogen activator inhibitor-1
Authors: Hovind, P Tarnow, L Rossing, P Teerlink, T Stehouwer, CDA Emeis, JJ Parving, HH
Citation: P. Hovind et al., Progression of diabetic nephropathy: Role of plasma homocysteine and plasminogen activator inhibitor-1, AM J KIDNEY, 38(6), 2001, pp. 1376-1380
Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis
Authors: Giltay, EJ Gooren, LJG Emeis, JJ Kooistra, T Stehouwer, CDA
Citation: Ej. Giltay et al., Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis, ART THROM V, 20(5), 2000, pp. 1396-1403
Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy
Authors: Tarnow, L Stehouwer, CDA Emeis, JJ Poirier, O Cambien, F Hansen, BV Parving, HH
Citation: L. Tarnow et al., Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy, NEPH DIAL T, 15(5), 2000, pp. 625-630
Oral contraceptives and hormone replacement therapy - Preface
Authors: Emeis, JJ Kooistra, T
Citation: Jj. Emeis et T. Kooistra, Oral contraceptives and hormone replacement therapy - Preface, CURR MED CH, 7(5), 2000, pp. NIL_2-NIL_2
Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation
Authors: Hellebrekers, BWJ Trimbos-Kemper, GCM Bakkum, EA Trimbos, JBMZ Declerck, PJ Kooistra, T Emeis, JJ
Citation: Bwj. Hellebrekers et al., Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation, THROMB HAEM, 84(5), 2000, pp. 876-881
Oral ethinyl estradiol, but not transdermal 17 beta-estradiol, increases plasma C-reactive protein levels in men
Authors: Giltay, EJ Gooren, LJG Emeis, JJ Kooistra, T Stehouwer, CDA
Citation: Ej. Giltay et al., Oral ethinyl estradiol, but not transdermal 17 beta-estradiol, increases plasma C-reactive protein levels in men, THROMB HAEM, 84(2), 2000, pp. 359-360
Impaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomised, placebo-controlled 12-week study
Authors: van Baal, WM Emeis, JJ van der Mooren, MJ Kessel, H Kenemans, P Stehouwer, CDA
Citation: Wm. Van Baal et al., Impaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomised, placebo-controlled 12-week study, THROMB HAEM, 83(1), 2000, pp. 29-34
Use of fibrinolytic agents in the prevention of postoperative adhesion formation
Authors: Hellebrekers, BWJ Trimbos-Kemper, TCM Trimbos, JBMZ Emeis, JJ Kooistra, T
Citation: Bwj. Hellebrekers et al., Use of fibrinolytic agents in the prevention of postoperative adhesion formation, FERT STERIL, 74(2), 2000, pp. 203-212
The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II Diabetic subjects
Authors: Yudkin, JS Panahloo, A Stehouwer, C Emeis, JJ Bulmer, K Mohamed-Ali, V Denver, AE
Citation: Js. Yudkin et al., The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II Diabetic subjects, DIABETOLOG, 43(9), 2000, pp. 1099-1106
Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes - The Hoorn study
Authors: Jager, A van Hinsbergh, VWM Kostense, PJ Emeis, JJ Nijpels, G Dekker, JM Heine, RJ Bouter, LM Stehouwer, CDA
Citation: A. Jager et al., Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes - The Hoorn study, DIABETES, 49(3), 2000, pp. 485-491
Simvastatin improves disturbed endothelial barrier function
Authors: Amerongen, GPV Vermeer, MA Negre-Aminou, P Lankelma, J Emeis, JJ van Hinsbergh, VWM
Citation: Gpv. Amerongen et al., Simvastatin improves disturbed endothelial barrier function, CIRCULATION, 102(23), 2000, pp. 2803-2809
Postmenopausal oestradiol-dydrogesterone therapy favourably affects fibrinolysis and Lp(a) in healthy women
Authors: Mijatovic, V Kenemans, P van der Mooren, MJ Emeis, JJ van Baal, WM Peters-Muller, ER Stehouwer, CDA
Citation: V. Mijatovic et al., Postmenopausal oestradiol-dydrogesterone therapy favourably affects fibrinolysis and Lp(a) in healthy women, FIBRINOL PR, 13(4-5), 1999, pp. 177-183
Hormone replacement therapy
Authors: Kooistra, T Emeis, JJ
Citation: T. Kooistra et Jj. Emeis, Hormone replacement therapy, CURR OP C B, 3(4), 1999, pp. 495-499
C-reactive protein in wealthy subjects: Associations with obesity, insulinresistance, and endothelial dysfunction - A potential role for cytokines originating from adipose tissue?
Authors: Yudkin, JS Stehouwer, CDA Emeis, JJ Coppack, SW
Citation: Js. Yudkin et al., C-reactive protein in wealthy subjects: Associations with obesity, insulinresistance, and endothelial dysfunction - A potential role for cytokines originating from adipose tissue?, ART THROM V, 19(4), 1999, pp. 972-978
von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects - The Hoorn study
Authors: Jager, A van Hinsbergh, VWM Kostense, PJ Emeis, JJ Yudkin, JS Nijpels, G Dekker, JM Heine, RJ Bouter, LM Stehouwer, CDA
Citation: A. Jager et al., von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects - The Hoorn study, ART THROM V, 19(12), 1999, pp. 3071-3078
Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women
Authors: van Baal, WM Kenemans, P van der Mooren, MJ Kessel, H Emeis, JJ Stehouwer, CDA
Citation: Wm. Van Baal et al., Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women, THROMB HAEM, 81(6), 1999, pp. 925-928
Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study
Authors: Gijbels, MJJ van der Cammen, M van der Laan, LJW Emeis, JJ Havekes, LM Hofker, MH Kraal, G
Citation: Mjj. Gijbels et al., Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study, ATHEROSCLER, 143(1), 1999, pp. 15-25
Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women
Authors: van Baal, WM Kenemans, P Emeis, JJ Schalkwijk, CG Mijatovic, V van der Mooren, MJ Vischer, UM Stehouwer, CDA
Citation: Wm. Van Baal et al., Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women, FERT STERIL, 71(4), 1999, pp. 663-670
Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules
Authors: van Baal, WM Emeis, JJ Kenemans, P Kessel, H Peters-Muller, ERA Schalkwijk, CG van der Mooren, MJ Stehouwer, CDA
Citation: Wm. Van Baal et al., Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules, EUR J CL IN, 29(11), 1999, pp. 913-921
Plasma concentration of C-reactive protein is increased in type I diabeticpatients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation
Authors: Schalkwijk, CG Poland, DCW van Dijk, W Kok, A Emeis, JJ Drager, AM Doni, A van Hinsbergh, VWM Stehouwer, CDA
Citation: Cg. Schalkwijk et al., Plasma concentration of C-reactive protein is increased in type I diabeticpatients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation, DIABETOLOG, 42(3), 1999, pp. 351-357
vonWillebrand factor (vWf) as a plasma marker of endothelial activation indiabetes: Improved reliability with parallel determination of the vWf propeptide (vWf : AgII)
Authors: Vischer, UM Emeis, JJ Bilo, HJG Stehouwer, CDA Thomsen, C Rasmussen, O Hermansen, K Wollheim, CB Ingerslev, J
Citation: Um. Vischer et al., vonWillebrand factor (vWf) as a plasma marker of endothelial activation indiabetes: Improved reliability with parallel determination of the vWf propeptide (vWf : AgII), THROMB HAEM, 80(6), 1998, pp. 1002-1007
Raman spectroscopy for quantifying cholesterol in intact coronary artery wall
Authors: Romer, TJ Brennan, JF Schut, TCB Wolthuis, R van den Hoogen, RCM Emeis, JJ van der Laarse, A Bruschke, AVG Puppels, GJ
Citation: Tj. Romer et al., Raman spectroscopy for quantifying cholesterol in intact coronary artery wall, ATHEROSCLER, 141(1), 1998, pp. 117-124
Risultati: 1-25 |